Larvol Delta - VICTORION2P-Study-of-Inclisiran-to-Prevent-Cardiovascular-CV-Events-in-Participants-With-Established-Cardiovascular-Disease

Leqvio (inclisiran) - Novartis

http://clinicaltrials.gov/ct2/show/NCT05030428

Aug 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next